Preimplantation Genetic Diagnosis Market Sales Revenue Is Expected to Reach Us$118 Mn by 2020,According Tmr Research

Preimplantation genetic diagnosis (PGD) is the genetic profiling of embryos before they are implanted and can also be of oocytes before fertilization. It is an adjuvant technique to in vitro fertilization (IVF), used for the detection of genetic conditions or diseases prior to the embryo being implanted. PGD is utilized for the screening of a wide range of medical abnormalities such as inheritable diseases, Down’s syndrome, and traits of a number of other physiological abnormalities. In addition, the utilization of array comparative genomic hybridization (aCGH) as well as fluorescent in situ hybridization (FISH) techniques within PGD has enhanced the overall success rate and process efficiency of pregnancy via IVF.

Download Free Sample Report Brochure PDF:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=427

As per the report, the delay in conception among women has raised the demand for PGD. In addition, the rising occurrence of genetic diseases prompts patients to undergo PGD cycles in order to have a disease-free offspring. Increasing lifestyle changes such as stress, pollution, and smoking have resulted in decreased fertility in females, thus propelling the demand for PGD and IVF. Various innovations for the prevention of cancer and developments within the genetics field have emerged as key growth opportunities in the market for PGD. On the other hand, the limited insurance coverage for PGD and IVF has deterred patients from availing these techniques, hence inhibiting the development of the market. In addition, the social and economic factors associated with the usage of IVF will negatively impact the market.

On the basis of test type, the report segments the market into PGD for chromosomal aberrations, PGD for aneuploidy screening, PGD for single gene disorder, PGD for gender selection, PGD for X-linked diseases, and PGD for HLA typing. Amongst these, PGD for aneuploidy screening led the market in 2013 owing to the fact that...